Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive 

Giegling, I; Drago, A; Dolžan, V; Plesničar, B K; Schäfer, M; Hartmann, A M; Sander, T; Toliat, M R; Möller, H J; Stassen, H H; Rujescu, D; Serretti, A (2011). Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. Pharmacogenetics and Genomics, 21(4):206-216.

Full text not available from this repository.

Abstract

BACKGROUND: The glutamatergic system may be relevant to the pathophysiology of psychosis and to the effects of antipsychotic treatments. OBJECTIVES: We investigated a set of 62 SNPs located in genes coding for subunits of glutamatergic receptors (GAD1, GRIA1, GRIA3, GRIA4, GRID2, GRIK1, GRIK2, GRIK3, GRIK4, GRIN2B, GRM1 and GRM4), and the transporter of glycine (SLC6A5), as modulators of the effects of haloperidol. METHODS AND RESULTS: We studied a sample of 101 acutely ill psychotic patients. We then validated our result in two independent samples from Slovenia (n=71 and n=118) of schizophrenic patients treated with antipsychotics. We both investigated the antipsychotic effect (Positive and Negative Syndrome Scale) and motor side effect (Extrapyramidal Symptom Rating Scale) at baseline and days 3, 7, 14, 21 and 28. SLC6A5 variant (rs2298826) was found to be associated with a rapid rise of motor side effects at the beginning of the treatment (repeated measures of analysis of variance, P=0.0002), followed by a subsequent adaptation, probably dependent on haloperidol doses down titration. A specific effect was noted for dyskinetic symptoms. Haplotype analysis strengthened the relevance of SLC6A5: the C-A-C haplotype (rs1443548, rs883377, rs1945771) was found to be associated with higher Extrapyramidal symptom rating scale scores (overall P=0.01, haplotype P=0.000001). We successfully replicated this finding in the two independent samples from Slovenia. CONCLUSION: This result further stresses the relevance of the glutamatergic system in modulating the effects of haloperidol treatment, especially with regards to motor side effects.

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Institute of Response Genetics
DDC:UNSPECIFIED
Language:English
Date:2011
Deposited On:27 Feb 2011 13:20
Last Modified:27 Nov 2013 16:31
Publisher:Lippincott Wiliams & Wilkins
ISSN:1744-6872
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:10.1097/FPC.0b013e32833efb18
PubMed ID:20859245
Citations:Web of Science®. Times Cited: 7
Google Scholar™
Scopus®. Citation Count: 8

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page